par Body, Jean-Jacques
Référence Current opinion in oncology, 23, 4, page (338-342)
Publication Publié, 2011-07
Référence Current opinion in oncology, 23, 4, page (338-342)
Publication Publié, 2011-07
Article révisé par les pairs
Titre: |
|
Auteur: | Body, Jean-Jacques |
Informations sur la publication: | Current opinion in oncology, 23, 4, page (338-342) |
Statut de publication: | Publié, 2011-07 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | bone metastases |
denosumab | |
prevention | |
zoledronic acid | |
MeSH keywords: | Antibodies, Monoclonal -- therapeutic use |
Antibodies, Monoclonal, Humanized | |
Bone Density Conservation Agents -- therapeutic use | |
Bone Neoplasms -- drug therapy -- prevention & control -- secondary | |
Bone Resorption -- drug therapy -- prevention & control | |
Bone and Bones -- pathology | |
Breast Neoplasms -- secondary | |
Clinical Trials as Topic | |
Diphosphonates -- therapeutic use | |
Female | |
Humans | |
Imidazoles -- therapeutic use | |
Jaw -- pathology | |
Male | |
Neoplasm Recurrence, Local | |
Osteonecrosis | |
Prostatic Neoplasms -- secondary | |
RANK Ligand -- therapeutic use | |
Note générale: | Journal Article |
Review | |
SCOPUS: re.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:1040-8746 |
info:doi/10.1097/CCO.0b013e328347918b | |
info:scp/79958811058 | |
info:pmid/21519257 |